EXI1:XETRA:XETRA-iShares SLI UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 151.9

Change

+1.34 (+0.89)%

Market Cap

USD 0.37B

Volume

814.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.47 (+0.88%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.10 (+0.58%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.10 (+0.34%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.20 (+0.70%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.08 (+0.30%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.39 (-0.84%)

USD 102.61B
8R80:XETRA Amundi Index Solutions - Amund..

-2.60 (-1.81%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.31 (+0.59%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.24 (-0.22%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-2.82 (-0.46%)

USD 80.38B

ETFs Containing EXI1:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.36% 93% A 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.36% 93% A 88% B+
Trailing 12 Months  
Capital Gain 14.92% 60% D- 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.92% 59% D- 59% D-
Trailing 5 Years  
Capital Gain 42.36% 65% D 67% D+
Dividend Return 4.16% 19% F 15% F
Total Return 46.52% 66% D+ 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 9.96% 64% D 63% D
Dividend Return 10.27% 64% D 62% D
Total Return 0.31% 30% F 20% F
Risk Return Profile  
Volatility (Standard Deviation) 11.79% 55% F 63% D
Risk Adjusted Return 87.07% 76% C+ 79% B-
Market Capitalization 0.37B 59% D- 52% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.